Cresskill, NJ, United States of America

Seetharama A Acharya

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 2.2

ph-index = 5

Forward Citations = 60(Granted Patents)


Location History:

  • Creeskill, NJ (US) (2007)
  • Cresskill, NJ (US) (1982 - 2021)

Company Filing History:


Years Active: 1982-2021

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Seetharama A Acharya

Introduction

Seetharama A Acharya, based in Cresskill, NJ, is a noteworthy inventor with a remarkable portfolio of 12 patents to his name. His contributions primarily focus on advancing medical technology and improving therapeutic methods, particularly in the context of sickle cell disease and blood transfusions.

Latest Patents

Among his notable inventions are two recent patents that highlight his innovative approaches to healthcare. The first patent, titled "Method of ameliorating side effects of sickle cell disease treatments," introduces a method to alleviate cerebral tissue pathology associated with sickle cell disease therapies. This is achieved through the use of either a synthetic high-oxygen affinity hemoglobin-containing molecule or synthetically treated high-oxygen affinity blood. The second patent, "Method of enhancing efficacy of blood transfusions," details a technique aimed at improving the effectiveness of blood transfusions by administering a composition containing an EAF PEGylated-blood protein, either before, during, or after the transfusion process.

Career Highlights

Throughout his career, Acharya has worked with prestigious institutions, including the Albert Einstein College of Medicine of Yeshiva University and the Albert Einstein College of Medicine. His research and inventions have significantly contributed to the fields of hematology and transfusion medicine, paving the way for improvements in patient care.

Collaborations

Acharya's work has also seen collaborations with esteemed colleagues, notably Belur N Manjula and Marcos Intaglietta. Together, they have contributed to advancing the understanding and treatment of blood-related disorders.

Conclusion

Seetharama A Acharya's innovative spirit and dedication to enhancing medical treatments continue to make a profound impact on the lives of patients suffering from conditions like sickle cell disease. His extensive patent portfolio underscores his role as a leading figure in medical innovation, reflecting the potential for future advancements in healthcare technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…